Your institution may have access to this item. Find your institution then sign in to continue.
Title
Lessons learned from HIV-1 vaccine trials: new priorities and directions.
Authors
McMichael, Andrew J; Haynes, Barton F
Abstract
A vaccine against human immunodeficiency virus (HIV) seems to be on the horizon. Correlates of risk of infection for [corrected] the RV144 vaccine trial have been found. There is understanding of what makes HIV envelope-specific antibodies broadly neutralizing and new T cell vaccine approaches can overcome virus variability.